Related Experiment Video
Updated: May 28, 2026

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
Published on: October 5, 2021
Alterations of molecular and behavioral responses to cocaine by selective inhibition of Elk-1 phosphorylation
Antoine Besnard1, Nicolas Bouveyron, Vincent Kappes
1Inserm, Unité Mixte de Recherche en Santé 952, F-75005 Paris, France.
Abstract:
Activation of the extracellular signal-regulated kinase (ERK) signaling pathway in the striatum is crucial for molecular adaptations and long-term behavioral alterations induced by cocaine. In response to cocaine, ERK controls the phosphorylation levels of both mitogen and stress-activated protein kinase 1 (MSK-1), a nuclear kinase involved in histone H3 (Ser10) and cAMP response element binding protein phosphorylation, and Elk-1, a transcription factor involved in serum response element (SRE)-driven gene regulations. We recently characterized the phenotype of msk-1 knock-out mice in response to cocaine. Herein, we wanted to address the role of Elk-1 phosphorylation in cocaine-induced molecular, morphological, and behavioral responses. We used a cell-penetrating peptide, named TAT-DEF-Elk-1 (TDE), which corresponds to the DEF docking domain of Elk-1 toward ERK and inhibits Elk-1 phosphorylation induced by ERKs without modifying ERK or MSK-1 in vitro. The peptide was injected in vivo before cocaine administration in mice. Immunocytochemical, molecular, morphological, and behavioral studies were performed. The TDE inhibited Elk-1 and H3 (Ser10) phosphorylation induced by cocaine, sparing ERK and MSK-1 activation. Consequently, TDE altered cocaine-induced regulation of genes bearing SRE site(s) in their promoters, including c-fos, zif268, ΔFosB, and arc/arg3.1 (activity-regulated cytoskeleton-associated protein). In a chronic cocaine administration paradigm, TDE reversed cocaine-induced increase in dendritic spine density. Finally, the TDE delayed the establishment of cocaine-induced psychomotor sensitization and conditioned-place preference. We conclude that Elk-1 phosphorylation downstream from ERK is a key molecular event involved in long-term neuronal and behavioral adaptations to cocaine.
Insights
Elk-1 phosphorylation, downstream of ERK signaling, is critical for cocaine
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Extracellular signal-regulated kinase (ERK) pathway activation in the striatum drives cocaine-induced adaptations.
- ERK influences mitogen and stress-activated protein kinase 1 (MSK-1) and Elk-1 phosphorylation, impacting gene regulation and neuronal changes.
- Previous studies characterized msk-1 knock-out mice; this study investigates the role of Elk-1 phosphorylation.
Purpose of the Study:
- To determine the role of Elk-1 phosphorylation in cocaine's molecular, morphological, and behavioral effects.
- To investigate whether inhibiting Elk-1 phosphorylation affects cocaine-induced neuronal plasticity and addiction-related behaviors.
Main Methods:
- Utilized a cell-penetrating peptide (TAT-DEF-Elk-1 or TDE) to inhibit ERK-mediated Elk-1 phosphorylation in vivo.
- Administered TDE before cocaine exposure in mice.
- Conducted immunocytochemical, molecular, morphological, and behavioral analyses.
Main Results:
- TDE successfully inhibited cocaine-induced Elk-1 and histone H3 (Ser10) phosphorylation without affecting ERK or MSK-1.
- TDE altered the regulation of cocaine-responsive genes with serum response elements (SREs), including c-fos and ΔFosB.
- TDE reversed cocaine-induced increases in dendritic spine density and delayed psychomotor sensitization and conditioned place preference.
Conclusions:
- Elk-1 phosphorylation is a key molecular event downstream of ERK signaling in cocaine's long-term effects.
- Targeting Elk-1 phosphorylation offers a potential strategy for mitigating cocaine-induced adaptations and addiction.
More Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Desensitization and Tachyphylaxis
Several...

